rhinovirus infections cause majority acute exacerbations airway diseases asthma chronic obstructive pulmonary disease increased cytokine production infected bronchial epithelial cells contributing disease pathogenesis theses diseases huge cause morbidity worldwide contribute major economic burden healthcare costs current steroid based treatments partially efficient controlling virus induced inflammation remains unmet therapeutic goal implicated precise mechanisms rhinovirus induction gene expression bronchial epithelial cells unclear hypothesised rhinovirus replication generation dsrna important process cytokine induction using pharmalogical new small molecule inhibitor genetic inhibition dsrna binding kinase protein kinase r striking inhibition dsrna polyric rhinovirus induced ccl5 cxcl8 protein observed using confocal microscopy rhinovirus induced protein kinase r phosphorylation p65 nuclear translocation focusing cxcl8 rhinovirus infection dsrna treatment required ikappab induction cxcl8 analysis sites cxcl8 promoter revealed rhinovirus infection dsrna treatment upregulated cxcl8 promoter activation binding sites results demonstrate importance dsrna induction cytokines rhinoviruses suggest protein kinase r involved mediated gene transcription cytokines ikappab molecules regulating rhinovirus induction inflammation represent therapeutic targets pro inflammatory nf kappab pro inflammatory pro inflammatory NUMBER aminopurine il NUMBER located nf kappab kinase beta cis acting nf kappab nf il6 pro inflammatory nf kappab pro inflammatory kinase beta